Beardsley Robert A 4
4 · Arbutus Biopharma Corp · Filed Mar 20, 2025
Insider Transaction Report
Form 4
Beardsley Robert A
Director
Transactions
- Award
Stock Option (Right to Buy)
2025-03-18+157,600→ 157,600 totalExercise: $3.20Exp: 2035-03-18→ Common Shares (157,600 underlying)
Footnotes (2)
- [F1]Reflects the closing price of the Company's common shares on the Nasdaq Stock Market on the date of the grant.
- [F2]This option vests over a three-year period, with 1/3rd of the total shares subject to the option vesting at each of the 1st, 2nd, and 3rd anniversaries of the grant date, subject to the Reporting Person's continuous service as of each vesting date.